Data from the ongoing, prospective IMPACT study has shown that PSA velocity is not predictive of risk for a positive prostate cancer biopsy result in men who are carriers of the BRCA2 gene. As we begin to learn more about how to manage risk for prostate cancer in men with a known genetic predisposition for […]
↧